Achaogen announces plans to price its initial public offering of stock

Credit Suisse and Cowen are the joint bookrunning managers for deal

By Devika Patel

Knoxville, Tenn., Jan. 24 - Achaogen Inc. will price its initial public offering with a greenshoe option, according to a Form S-1 filed Friday with the Securities and Exchange Commission.

Credit Suisse and Cowen and Co. are the joint bookrunning managers. William Blair and Needham & Co. are the co-managers.

Proceeds will be used for research and development activities, working capital and general corporate expenditures.

The biopharmaceutical company is based in South San Francisco, Calif. It intends to list its common stock on the Nasdaq under the symbol "AKAO."

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.